The Immunotoxicity testing in the 21th century seminar

Welcome to the seminar

Immunotoxicity testing in the 21th century – recent developments within prediction of immunotoxicity using alternative methods.

The seminar will take place at the Medicon Village Aula (Hörsalen) on November 23, 2017 with the support from SenzaGen and Medicon village


13.15-13.30     Welcome
Prof. Malin Lindstedt, Dept. of Immunotechnology
Kerstin Jakobsson, Vice President, Medicon Village

13.30-14.00     From pathways to people: applying the skin sensitization adverse outcome pathway (AOP) 
Dr. Gavin Maxwell, Unilever’s Safety & Environmental Assurance centre, UK

14.00-14.30     Towards an AOP for chemical respiratory allergy
Prof. Ian Kimber, University of Manchester, UK

14.30-15.00     Coffee

15.00-15.30     Application of novel in vitro methods for the discovery of safe innovative medicines
Dr Jorrit Hornberg, Discovery Safety at AstraZeneca

15.30-16.00     Application of the AOP concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food protein
Dr Erwin Roggen, 3Rs Management and Consulting ApS

16.00-16.30     Progress towards GARDskin validation and GARDair implementation
Dr Henrik Johansson, SenzaGen AB

Please register before Nov 15 to

Link to program